Evolution of brain tuberculomas under standard antituberculous treatment

Area of Science:

• Neurology
• Infectious Diseases
• Radiology

Background:

• Brain tuberculomas are typically managed medically, with surgery reserved for diagnostic uncertainty or treatment failure.
• Understanding the radiological progression of intracranial tuberculomas under medical therapy is crucial for optimizing patient management.

Purpose of the Study:

• To evaluate the radiological evolution of brain tuberculomas during standard anti-tuberculous drug therapy.
• To establish evidence-based guidelines for the management of intracranial tuberculomas.

Main Methods:

• Retrospective analysis of 18 patients with brain tuberculomas treated solely with standard anti-tuberculous drugs.
• Serial computed tomography (CT) scans were used to monitor lesion regression, stabilization, or paradoxical enlargement.
• Patients were followed until complete lesion resolution or stabilization, with treatment duration assessed.

Main Results:

• Lesion size and number showed slow initial regression (mean -7.3% in the first month), followed by rapid decline (-15% to -20% per month).
• Three patients (all with meningitis) experienced paradoxical enlargement in the first month.
• Complete radiological resolution of tuberculomas was observed in all patients after 12 months of therapy; edema resolved by 6 months.

Conclusions:

• Standard anti-tuberculous therapy is effective, suggesting a 15-18 month regimen may not be necessary for non-immunocompromised patients.
• A minimum 2-month medical treatment trial is recommended for suspected intracranial tuberculomas before considering alternative diagnoses or surgical intervention.